The Essentials of Nutrition and Digestive Health in Pancreatic Cancer

Many cancer survivors experience fear of recurrence, even years into survivorship, so here are ways to help manage and face this fear.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Topline data has been released from a trial of antibody-drug conjugate FG-3246 for patients with pretreated, metastatic castration-resistant prostate cancer.

Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.

Compared to other treatments, patients’ testosterone levels return to baseline levels faster following treatment with Orgovyx.

Patients with prostate cancer receiving ADT who are vitamin D deficient may receive the most bone density benefits from high-dose vitamin D.